SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-003879
Filing Date
2013-01-23
Accepted
2013-01-22 17:31:22
Documents
10
Period of Report
2013-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-25051_88k.htm 8-K 36040
2 EX-1.1 a12-25051_8ex1d1.htm EX-1.1 391566
3 EX-10.1 a12-25051_8ex10d1.htm EX-10.1 244438
4 EX-10.2 a12-25051_8ex10d2.htm EX-10.2 243570
5 EX-99.1 a12-25051_8ex99d1.htm EX-99.1 17413
6 EX-99.2 a12-25051_8ex99d2.htm EX-99.2 11266
7 GRAPHIC g250518km01i001.jpg GRAPHIC 3969
8 GRAPHIC g250517bei001.jpg GRAPHIC 4907
9 GRAPHIC g250518kk01i001.jpg GRAPHIC 4187
10 GRAPHIC g250518moi001.jpg GRAPHIC 4801
  Complete submission text file 0001104659-13-003879.txt   970732
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13541115
SIC: 2834 Pharmaceutical Preparations